US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist

1.035
-0.035-3.27%

Trading Nov 21 10:13 ET

36.18MMarket Cap-372P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPT Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

RAPT Therapeutics Earnings Reports

RAPT Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 01:04

RAPT Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 20:14

RAPT Therapeutics | 10-Q: Q1 2024 Earnings Report

May 9 20:12

RAPT Therapeutics | 10-K: FY2023 Annual Report

Mar 7 21:09

Analyst Rating

Updated: Nov 13, 2024

Hold

Buy
14.29%
Hold
71.43%
Sell
14.29%

Price Target

No Data

Heat List

Overall